The American Court of Appeal of the Federal Department agreed today, by previously, by its previously issued Patent and Appeal Council of the US Patent and Brand Office (PTAB). This ruling found that three patents owned by the ALIVECOR Technology Company "are not extension". As a result, the International Trade Committee (ITC) cannot set an import ban on the Apple Watch models that contain the heart rate screen in the United States

This case started in 2021 when Alivecor went to the International Trade Committee (ITC) complaining that Apple violated three patents related to the Apple Watch heart rate sensor. ITC ruling in favor of Alivecor in 2021, forcing Apple to attract PTAB. PTAB was found in favor of Apple saying that the three patents were "unacceptable". Alivecor decided to appeal this decision. A few weeks later, ITC ruled in favor of Alivecor and said that Apple had not violated the above patents listed and found to be valid.

ITC was in writing an exclusion order that would have prohibited import in the United States of Apple Watch models that contained the heart rate screen found in the Alivecor patent violation. The import ban would affect each current Apple Watch that is being sold in the United States at the time because they all offered the monitoring of the heart rate. However, ITC stopped the exclusion order and decided to wait until a ruling on the legitimacy of the three patent patents was issued. Remember that PTAB has previously described patents as "not approved."

Alivecor statement said that the company was disappointed and accused PTAB of not passing by secondary considerations by ITC when it ruled that the patents were valid.

The monitoring of the heart rate measures the number of rhythms in the minute achieved by the Apple Watch user. If this number is very low or very high compared to a pre -pre -established scale created by the user, a notification will be sent to the user of the device that may have to see the doctor immediately if the heart rate is beyond the pre -setting range.